Several lncRNA have been reported to serve as oncogenes in BC, such as H19, MALAT1, TUG1, UCA1 32-35, emphasizing the potential for lncRNA to serve as biomarkers and therapeutic targets in BC. This evidence concerns the gene H19 and breast cancer.